Tissue distribution of exaprolol in rat

  • V. Faberová
  • T. Trnovec
  • M. Zemánek
  • Š. Bezek
  • M. Ďurišová
  • O. Tomčíková
Original Papers
  • 10 Downloads

Summary

The disposition of the beta adrenoceptor blocking drug 1-(2-cyclohexylphenoxy)-3-isopropylamino-2-propanol, exaprolol, in organs of the rat has been studied. After i.v. administration of3H-exaprolol a transient extremely high accumulation of the drug in lungs was observed with a peak of 7.7% of dose/g 30 min post-administration. The disposition pattern in heart, kidneys and liver may be characterized by a tissue to plasma ratio about ten. Lower exaprolol tissue levels were observed after oral administration. The tissue to plasma ratios showed an initial increase followed by constant levels. The distribution of exaprolol in organs of the rat is discussed in the light of the previously determined pharmacokinetic parameters.

Key-words

exaprolol distribution tissue rats beta-blockers 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Carissimi M., Gentili P., Grumelli E., Milla E., Picciola G. and Ravenna F. (1976): Basic ethers of cyclohexyl phenols with β-blocking activity. Arzneim.-Forsch.,26, 506–516.Google Scholar
  2. 2.
    Jendrichovský J., Rybár A., Štibrányi L., Dřímal J. and Jendrichovská M. (1978): 3-amino-l-cyclohexylaryloxy-2-propanols. Coll. Czech. Chem. Comm.,43, 1100–1107.Google Scholar
  3. 3.
    Hughes B., Kane K.A., McDonals F.M. and Parratt J.R. (1984): Aspects of the cardiovascular pharmacology of exaprolol. J. Pharm. Pharmacol.,36, 597–602.PubMedGoogle Scholar
  4. 4.
    Trnovec T., Zemánek M., Faberová V., Bezek Š., Ďurišová M., Ujházy E. and Tomčíkova O. (1982): Disposition of exaprolol, a new beta blocker, in rats. Drug Metab. Disp.,10, 547–551.Google Scholar
  5. 5.
    Hayes A. and Cooper R.G. (1971): Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey. J. Pharmacol. Exp. Therap.,176, 302–311.Google Scholar
  6. 6.
    Bodin N.O., Borg K.O., Johansson R., Obianwu H. and Svensson R. (1974): Absorption, distribution and excretion of alprenolol in man, dog and rat. Acta pharmacol. et toxicol.,35, 261–269.Google Scholar
  7. 7.
    Hemsworth B.A. and Street J.A. (1979): In vitro accumulation of (±)-oxprenolol by rat lung. Brit. J. Pharmacol.,66, 439 p.Google Scholar
  8. 8.
    Street J.A., Gonda I., Parkinson H. and Hemsworth B.A. (1978): Lung accumulation of some β-adrenoceptor antagonists. J. Pharm. Pharmacol.,30 suppl., 56 p.Google Scholar

Copyright information

© Springer-Verlag 1985

Authors and Affiliations

  • V. Faberová
    • 1
  • T. Trnovec
    • 1
    • 2
  • M. Zemánek
    • 1
    • 2
  • Š. Bezek
    • 1
    • 2
  • M. Ďurišová
    • 1
    • 2
  • O. Tomčíková
    • 1
    • 2
  1. 1.Institute of Experimental Pharmacology, Centre of Physiological SciencesSlovak Academy of SciencesBratislavaCzechoslovakia
  2. 2.Drug Research InstituteModraCzechoslovakia

Personalised recommendations